Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Johan Broekman

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2005
Ectonucleoside triphosphate diphosphohydrolase 1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosisTakuji Machida, Paul M Heerdt, Alicia C Reid, et al.
The Journal of Laboratory and Clinical Medicine|March 29, 2002
Role of a novel soluble nucleotide phospho-hydrolase from sheep plasma in inhibition of platelet reactivity: hemostasis, thrombosis, and vascular biologyAlex V Birk, Darya Bubman, M Johan Broekman, et al.
The Journal of Laboratory and Clinical Medicine|September 25, 2002
Role of extracellular ATP metabolism in regulation of platelet reactivityAlex V Birk, M Johan Broekman, Eva M Gladek, et al.
Journal of Translational Medicine|May 8, 2007
CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemiaDianne Pulte, Kim E Olson, M Johan Broekman, et al.
The Journal of Laboratory and Clinical Medicine|May 16, 2006
Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular diseaseM Teresa Santos, Juana Vallés, Justo Aznar, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2011
CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemiaDianne Pulte, Richard R Furman, M Johan Broekman, et al.
The Journal of Clinical Investigation|October 21, 2009
Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysisAndrew T Jacovina, Arunkumar B Deora, Qi Ling, et al.
Science Translational Medicine|August 8, 2014
Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding riskDouglas Moeckel, Soon Soeg Jeong, Xiaofeng Sun, et al.
Journal of Thrombosis and Thrombolysis|July 30, 2005
Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine ModelJohn M Buergler, Charles R Maliszewski, M Johan Broekman, et al.
Archives of Biochemistry and Biophysics|October 24, 2002
Cell-type specificity of ectonucleotidase expression and upregulation by 2,3,7,8-tetrachlorodibenzo-p-dioxinEmily Wood, M Johan Broekman, Terence L Kirley, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2005
Ectonucleoside triphosphate diphosphohydrolase 1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosisTakuji Machida, Paul M Heerdt, Alicia C Reid, et al.
The Journal of Laboratory and Clinical Medicine|March 29, 2002
Role of a novel soluble nucleotide phospho-hydrolase from sheep plasma in inhibition of platelet reactivity: hemostasis, thrombosis, and vascular biologyAlex V Birk, Darya Bubman, M Johan Broekman, et al.
The Journal of Laboratory and Clinical Medicine|September 25, 2002
Role of extracellular ATP metabolism in regulation of platelet reactivityAlex V Birk, M Johan Broekman, Eva M Gladek, et al.
Journal of Translational Medicine|May 8, 2007
CD39 activity correlates with stage and inhibits platelet reactivity in chronic lymphocytic leukemiaDianne Pulte, Kim E Olson, M Johan Broekman, et al.
The Journal of Laboratory and Clinical Medicine|May 16, 2006
Aspirin therapy for inhibition of platelet reactivity in the presence of erythrocytes in patients with vascular diseaseM Teresa Santos, Juana Vallés, Justo Aznar, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2011
CD39 expression on T lymphocytes correlates with severity of disease in patients with chronic lymphocytic leukemiaDianne Pulte, Richard R Furman, M Johan Broekman, et al.
The Journal of Clinical Investigation|October 21, 2009
Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysisAndrew T Jacovina, Arunkumar B Deora, Qi Ling, et al.
Science Translational Medicine|August 8, 2014
Optimizing human apyrase to treat arterial thrombosis and limit reperfusion injury without increasing bleeding riskDouglas Moeckel, Soon Soeg Jeong, Xiaofeng Sun, et al.
Journal of Thrombosis and Thrombolysis|July 30, 2005
Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine ModelJohn M Buergler, Charles R Maliszewski, M Johan Broekman, et al.
Archives of Biochemistry and Biophysics|October 24, 2002
Cell-type specificity of ectonucleotidase expression and upregulation by 2,3,7,8-tetrachlorodibenzo-p-dioxinEmily Wood, M Johan Broekman, Terence L Kirley, et al.
Pageof 3